Table 3.

Summary of Stem Cell/Exosomes Towards Effective Control of Diabetic Wounds

Cell Types	Systems	Characteristic	References
SMSC exosomes	CS Wound Dressings	Overexpression microRNA-126-3p exosomes.	[118,119]
AMSCs exosomes	OHA hydrogels	Bioactive multifunctional properties (injectability, self-healing, antibacterial activity, stimuli-responsive exosomes release).	[116]
GMSCs Exosomes	CS/Silk hydrogel sponge	Combination of GMSC-derived exosomes and hydrogel.	[114]
ASCs exosomes	FEP dressing	Injectable adhesive thermosensitive multifunctional dressing.	[117]
hASC exosome	hASC-exos carrying miR-21-5p as a cargo by electroporation	Combination of ASC-exos with miR-21 to achieve synergetic therapeutic.	[115]
hiPSCs	AHA hydrogels	Engineering vascularized constructs.	[103]
ASCs	PEG-gelatin hydrogel	Delivery of allogeneic ASCs in vivo.	[95]
MSCs	RGO nanoparticles	Acellular dermal composite scaffold.	[96]
ADSCs	GSL cryogels	Delivering ADSCs on antioxidant GS scaffolds coated with GSL, an endothelial basement protein to improve angiogenesis.	[98]
M2 phenotype macrophages	HHA hydrogel	Multiple modulation mechanisms of immunocompromise and angiogenesis.	[97]
Decellularized ECM	dECM hydrogels	Hydrogels derived from genetically engineered.	[100,101]
ECM-biomimetic cell-free nanofibrous	Bone ECM-biomimetic nanofibrous scaffolds	Without additional growth factors.	[99]